Exclusive Summary

• Holds top-tier US-FDA and UK-MHRA GMP certifications and is already registered in the US, serving as a 'golden passport' for immediate US commercialization and expedited regulatory approvals or tender winnings in emerging markets.
• One of the most widely prescribed broad-spectrum fluoroquinolone antibiotics, listed on the WHO Essential Medicines List, catering to massive and highly stable demand from hundreds of millions of patients suffering from UTIs, respiratory, and GI infections annually.
• Backed by the robust manufacturing economies of scale from a premium Chinese supplier, offering the perfect combination of Western-level compliance and significant cost efficiencies, thereby maximizing distribution margins and tender competitiveness.